Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Lymphoid 1Genitourinary 1Breast 1

Conditions

Urinary Bladder Neoplasms 1Prostatic Neoplasms 1Multiple Myeloma 1Leukemia, Myeloid 1Leukemia, Monocytic, Acute 1Leukemia, Lymphoid 1Leukemia 1Kidney Neoplasms 1Hodgkin Disease 1Breast Neoplasms 1

Interventions

fludarabine 7Tacrolimus 6fludarabine phosphate 5Whole-Body Irradiation 5Cyclophosphamide 5Busulfan 5Peripheral Blood Stem Cell Transplantation 4Mycophenolic Acid 4Methotrexate 4Sirolimus 3Melphalan 3Cytarabine 3Bone Marrow Transplantation 3thymoglobulin 2ponatinib 2Patient Reported Outcome Measures 2Mesna 2Behavior Therapy 2quizartinib 1nicotinamide-beta-riboside 1methanesulfonic acid 1etoposide phosphate 1blinatumomab 1Thiotepa 1Stem Cell Transplantation 1Social Determinants of Health 1RFT5-SMPT-dgA immunotoxin 1Photopheresis 1Panobinostat 1Immunotherapy, Adoptive 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia, Myeloid × Social Determinants of Health × Lymphoid × Clear all
NCT05871008 2025-09-15

Integrated Actionable Aging Assessment for Cancer Patients Pilot

University of Colorado, Denver

Phase NA Active not recruiting
35 enrolled
BreastGenitourinaryLymphoidOther hematologic neoplasmPlasma cell

Urinary Bladder Neoplasms, Breast Neoplasms, Hodgkin Disease, Kidney Neoplasms, Leukemia, Leukemia, Lymphoid, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Multiple Myeloma, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡